Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens.

Gigante, E; Deli, I; Gallina, S; De Santis, E; Delle Fave, G; Marignani, M

Gigante, E; Deli, I; Gallina, S; De Santis, E; Delle Fave, G; Marignani, M.

Affiliation

Gigante E; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy. Electronic address: whitegiant@hotmail.it.
Deli I; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.
Gallina S; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.
De Santis E; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.
Delle Fave G; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.
Marignani M; Digestive and Liver Disease Department, Second Medical Faculty, University "Sapienza", Azienda Ospedaliera S. Andrea, Rome, Italy.

Ann Oncol ; 22(6): 1462-1463, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21525405

Subject(s)

Antibodies, Monoclonal, Murine-Derived/adverse effects; Antineoplastic Agents/adverse effects; Hepatitis B virus; Hepatitis B/chemically induced; Lymphoproliferative Disorders/drug therapy; Female; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Antibodies, Monoclonal, Murine-Derived / Hepatitis B / Lymphoproliferative Disorders / Antineoplastic Agents Limits: Female / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google